Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan · Delayed Price · Currency is TWD 32.20
+0.10 (0.31%)
Aug 26, 2026, 1:34 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.46 billion as of August 25, 2026. Its market cap has increased by 81.87% in one year.
Market Cap
1.46B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
32.20
ChartMarket Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.46B, an increase of 30.89%. That is a compound annual growth rate of 7.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.51B | 36.83% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 1.85B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.81B |
| Sunny Pharmtech | 1.80B |
| Synbio Tech | 1.56B |
| Greenyn Biotechnology | 1.55B |
| Anti-Microbial Savior BioteQ | 1.53B |
| Advagene Biopharma | 1.51B |
| TaiRx | 1.41B |